Cargando…
Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm
The issue of iron overload in hemopoietic cell transplantation has been first discussed in the field of transplantation for thalassemia. Thalassemia major is characterized by ineffective erythropoiesis and hemolysis leading to severe anemia. Patients require regular blood transfusion therefore they...
Autores principales: | Pilo, Federica, Angelucci, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548208/ https://www.ncbi.nlm.nih.gov/pubmed/31205634 http://dx.doi.org/10.4084/MJHID.2019.030 |
Ejemplares similares
-
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022) -
Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017) -
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021) -
Storage of hemopoietic stem cells
por: Pamphilon, Derwood, et al.
Publicado: (2007) -
Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations
por: Riezzo, Irene, et al.
Publicado: (2017)